Abcam Limited

8 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Abcam PLC (to 2024)

Ending by 2030

Apr 2027

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due May 3, 2027
The maintenance fee for Production of conjugates (US 9,176,125) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 8,785,203	Protein detection reagents and methods with dyes and dextrins In force Term ends Apr 30, 2027 · From the USPTO record	In force	Term ends Apr 30, 2027	From the USPTO record
US 8,778,277	Protein detection reagents and methods with dyes and dextrins In force Term ends Feb 15, 2028 · From the USPTO record	In force	Term ends Feb 15, 2028	From the USPTO record
US 9,176,125	Production of conjugates In force Term ends Jun 12, 2028 · From the USPTO record	In force	Term ends Jun 12, 2028	From the USPTO record
US 8,492,129	Production of conjugates In force Term ends May 24, 2029 · From the USPTO record	In force	Term ends May 24, 2029	From the USPTO record
US 8,877,892	Conjugation reactions In force Term ends Jun 1, 2031 · From the USPTO record	In force	Term ends Jun 1, 2031	From the USPTO record
US 11,046,753	Antibody composition and buffer system therefor In force Term ends May 30, 2034 · From the USPTO record	In force	Term ends May 30, 2034	From the USPTO record
US 10,975,392	Site-Directed CRISPR/Recombinase Compositions and Methods of Integrating Transgenes In force Term ends Dec 7, 2035 · High confidence	In force	Term ends Dec 7, 2035	High confidence
US 12,264,193	Method for producing a recombinant allotypespecific rabbit monoclonal antibody In force Term ends Jan 10, 2039 · From the USPTO record	In force	Term ends Jan 10, 2039	From the USPTO record

Also on record, not counted in the 8: 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 no status recorded

List them